Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Earnings Call Transcript: Key Takeaways

KIMS delivered strong revenue growth led by Kondapur's rapid ramp-up, despite temporary margin compression from new oncology programs.

Krishna Institute of Medical Sciences Other Announcement

KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.

Krishna Institute of Medical Sciences Management Change

KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.

Execution

5 years

Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways

Q2 FY27 total revenue Rs13,630 Mn (+41.3% YoY), EBITDA Rs2,789 Mn (20.5% margin), PAT Rs757 Mn (+5.1% YoY). Expansion via 700+ beds planned.

Krishna Institute of Medical Sciences Results Update

KIMS reported Q2 FY27 consolidated revenue of Rs 1,363 Crore, up 41.3% YoY, with PAT of Rs 76 Crore. EBITDA rose 34% YoY to Rs 279 Crore.

Krishna Institute of Medical Sciences Q2 FY27 Results: Net Profit ₹74.6 Cr, Up 3.6% YoY

Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,344 Cr (+39.9% YoY) and net profit of ₹74.6 Cr (+3.6% YoY) for Q2 FY27.

Key figure

Net profit ₹74.6 Cr · +3.6% YoY

Krishna Institute of Medical Sciences Capacity Expansion

KIMS Saveera Hospital in Anantapur expanded from 250 to 500 beds, with new oncology and mother-and-child blocks inaugurated November 1, 2026. No monetary value disclosed.

hospital beds

250.0 beds

Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr

KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.

Value

₹15.00 Cr

Krishna Institute of Medical Sciences Acquisition Worth ₹79.5 Cr

KIMS Ltd acquired a 51% stake in Sarvottam Health Care Private Limited for up to ₹79.50 Crore, aiming to expand its healthcare operations in Kakinada.

Value

₹79.50 Cr

Krishna Institute of Medical Sciences Legal & Regulatory

KIMS discloses a pending suit over its Chennai hospital land lease, naming it defendant. Supreme Court dismissed its SLP; no injunction halts the project.

Krishna Institute of Medical Sciences Board Meeting Date

KIMS Ltd informed exchanges of a Board Meeting on November 4, 2026 to approve Q2 and H1 unaudited results. Trading window closes until 48 hours post-disclosure.

Krishna Institute of Medical Sciences Other Announcement

The company filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.